The current healthcare environment reshapes the three key factors in market access – value, evidence, and commercial positioning of new treatments. Greater emphasis on patient centricity meets budget cuts. Leading to a sharper focus on demonstrating patient benefit value specific… Continue Reading
Supplier Spotlight® highlights the unique skill sets and service offerings from organizations who are part of our CONNECTED COMMUNITY™. Below is an interview with Market Access & Pricing Strategy (MArS), the German-speaking market access experts. Tell us about MArS Market Access… Continue Reading
The new model of access strategy should build around four key pillars, says Jeff Weisel, Senior Advisor Asia-Pacific, PRMA Consulting. In this update, Jeff explores why the shifting currents of global healthcare are dictating a new approach to market access. Continue Reading
The complex, costly, and continuously evolving arena of biopharmaceutical product development demands a constant eye on commercialization potential. Continue Reading
In the first of a two-part series on early engagement with payers, Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Allen Lising, Managing Director of FormularyDecisions at Xcenda to discusss this innovative platform. Continue Reading
